Clinical outcome of 1,000 consecutive cases of liver transplantation: a single center experience.
10.4174/astr.2018.95.5.267
- Author:
Bong Jun KWAK
1
;
Dong Goo KIM
;
Jae Hyun HAN
;
Ho Joong CHOI
;
Si Hyun BAE
;
Young Kyoung YOU
;
Jong Young CHOI
;
Seung Kew YOON
Author Information
1. Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. kimdg@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Liver transplantation;
Cause of death;
Survival;
Risk factors
- MeSH:
Carcinoma, Hepatocellular;
Cause of Death;
Graft Rejection;
Humans;
Liver Transplantation*;
Liver*;
Living Donors;
Mortality;
Recurrence;
Risk Factors;
Survival Rate;
Tissue Donors
- From:Annals of Surgical Treatment and Research
2018;95(5):267-277
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The aim of this study was to analyze survival outcomes in 1,000 consecutive liver transplantations (LTs) performed at a single institution from 1993 to April 2017. METHODS: The study population was divided into 2 groups based on donor type: deceased donor LT (DDLT; n = 181, 18.1%) and living donor LT (LDLT; n = 819; 81.9%), and into 3 periods based on the number of cases (first 300 cases, middle 300 cases, last 400 cases). RESULTS: Infection was the most common cause of death, accounting for 34.8% (95 of 273). Mortality due to hepatocellular carcinoma recurrence occurred most frequently between 1 and 5 years after transplantation. Mortality rate by graft rejection was highest between 5 and 10 years after transplantation. And mortality by de novo malignancy occurred most frequently after 10 years after transplantation. The patient survival rates for the entire population at 5 and 10 years were 74.7%, and 68.6%, respectively. There was no difference in survival rate between the LDLT and DDLT groups (P = 0.188). Cause of disease, disease severity, case period, and retransplantation had a significant association with patient survival (P = 0.002, P = 0.031, P = 0.003, and P = 0.024, respectively). CONCLUSION: Surgical techniques and perioperative management for transplant patients have improved and undergone standardization. Controlling perioperative infection and managing patients with HCC as LT candidates will result in better outcomes.
